HTG is a transcriptomics company developing novel drug candidates and profiling diagnostics to determine the right therapy for the right patient.

News & Events

HTG Molecular Diagnostics to Present at H.C. Wainwright’s 23rd Annual Global Investment Conference

TUCSON, Ariz. , Sept. 08, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright’s 23rd Annual Global Investment Conference ,…

Keep Reading

HTG Molecular Diagnostics Reports Second Quarter 2021 Results

Call scheduled for today, August 12, at 4:30pm ET TUCSON, Ariz. , Aug. 12, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the quarter ended June 30, 2021…

Keep Reading

HTG’s New HTG Transcriptome Panel Launched with Commercial Availability in the U.S. and Europe

HTG Transcriptome Panel designed to measure approximately 20,000 mRNA targets using the  HTG EdgeSeq technology Intended to serve as one of the technological cornerstones for the  recently announced HTG Therapeutics Business Unit A third white paper highlighting the HTG Transcriptome Panel’s…

Keep Reading

Publications

Read white papers or journal publications and view other scientific content. 

White Papers

Posters

Abstracts

Webinars

Peer Reviewed Publications

Editorials

Reviews


Careers at HTG

At HTG, we are always looking for talented individuals to help us deliver our next-generation sequencing-based products throughout the world.

New Careers

Vice President of Marketing

Scientist - Development

Marketing Manager / Product Manager

Marketing Communications

Customer Order/Service Specialist

In House Counsel

See All Careers


Page last updated August 04, 2021